GREY:ATBPF - Post by User
Comment by
MrMugsyon Mar 11, 2023 11:03am
176 Views
Post# 35332474
RE:RE:RE:Happy Long Term Investor
RE:RE:RE:Happy Long Term InvestorYa - I'm not worried about dilution and you bring up a good point about the warrants.
The past year and a half have seen some intereting developments and they were all brought on by the human liver issues. Initially, the issue scared me but the reality of the gained learning hit me quickly. I think the ROS was a timely development and it should make us stronger. Not that I like the ROS development but we now know it was inevitable. Not sure how much sooner we would have wanted to figure it out anyway - best that we filled the bank up with cash first. A world of difference now that we have cash to work with.
Sure - we could have went to SVB for funding at this time ... hahaha !
The parallel path for acute/chronic and working on a better formulation is a perfect combination - what you'd expect to see from a company that isn't going to let these setbacks get in the way.
With any luck, end-of-year P2-acute helps drive this bus - sets us up with investor excitement and gets us thinking co-listing. Issuing shares to drive additional co-listing demand is a perfect way to add a few more shares (if demand outstrips supply). Going into 2024 could also allow us to bank a few more dollars from expiring warrants - if - they can pull off a very nice P2-Acute readout.
Also ... DILIsym should be a powerful tool for our needs. First with Acute, then with IBD ... and ... finally with Chronic (based on the fact we're using it in acute now).
Time will tell where we are - but - I like how it's coming together.